Skip to main content

Editorial Board

Michael Pollak, McGill University and Lady Davis Research Institute, Canada
Matthew Vander Heiden, Massachusetts Institute of Technology, USA

Editor Emeritus
Chi Van Dang, Abramson Cancer Centre, University of Pennsylvania, USA

Associate Editors
Kivanc Birsoy, The Rockefeller University, USA
Kevin Brindle, University of Cambridge, UKTeresa Fan, Markey Cancer Center, USA
Navdeep Chandel, Northwestern University, USA
Teresa Fan, Markey Cancer Center, USA
Rudolf Kaaks, German Cancer Research Center, Germany
Costas Lyssiotis, Harvard Medical School, USA
Richard G. Kibbey, Yale University School of Medicine, USA
Alexei Vazquez, University of Glasgow, College of Medical, Veterinary and Life Sciences

Editorial Board
Abass Alavi, University of Pennsylvania School of Medicine, USA
Lewis Cantley, Weill Cornell Medical College, USA
Peter Carmeliet, Vesalius Research Center, Belgium
Robert Gatenby, H. Lee Moffitt Cancer Center and Research Institute, USA
Kun-Liang Guan, University of  California, San Diego, USA
Andrew Lane, Markey Cancer Center, USA
Gordon Mills, University of Texas M. D. Anderson Cancer Center, USA
Jacques Pouyssegur, Institute of Research on Cancer and Aging, France
Joshua Rabinowitz, Princeton University, USA
Peter Ratcliffe, Nuffield Department of Clinical Medicine, UK
Jeffrey Rathmell, Duke University, USA
Jared Rutter, University of Utah School of Medicine, USA
David Sabatini, Whitehead Institute for Biomedical Research, USA
Paolo Sassone-Corsi, University of California, Irvine, USA
Gregg Semenza, Johns Hopkins University School of Medicine, USA
Celeste Simon, University of Pennsylvania School of Medicine, USA
Bert Vogelstein, Johns Hopkins University School of Medicine, USA
Karen Vousden, Beatson Institute for Cancer Research, UK
Kathryn Wellen, University of Pennsylvania, USA
Eileen White, The Cancer Institute of New Jersey, USA
Yue Xiong, University of North Carolina, Chapel Hill, USA

Impact of COVID-19

COVID-19 © elipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.

Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license.

Annual Journal Metrics

  • Speed
    65 days to first decision for reviewed manuscripts only
    59 days to first decision for all manuscripts
    135 days from submission to acceptance
    35 days from acceptance to publication

    Citation Impact

    5.033 - 2 Year Impact Factor
    0.583 - Immediacy Index

    210 Altmetric Mentions